Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
torques supplementation attenuated #Colitis severity through enhancing epithelial integrity (#Claudin_3, 3.3-fold
risk of edema, fractures, bladder cancer Non-Insulin Injectable Agents (assign Z79.85): GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide, tirzepatide [dual GIP/GLP-1]): Cardiovascular and renal protective
Semaglutide, a GLP-1 receptor agonist, is one of the advanced medications we prescribe to help manage blood sugar levels and support weight loss when clinically appropriate
Overall, the newer small molecule GLP-1 RAs such as danuglipron and orforglipron have shown significant reductions in HbA1c and body weight, comparable to existing GLP-1 RAs
All GLP-1 receptor agonists and tirzepatide carry a boxed warning for risk of thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)